Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone changes after jejunoileal bypass for obesity]

M Príkazská, I Beno, V Makovický

    Ceskoslovenska Radiologie
    |November 1, 1983
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Campylobacteriosis in the South Bohemian Region - a Recurrent Problem.

    Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne·2016
    Same author

    Outbreak of listeriosis in the Czech Republic, late 2006--preliminary report.

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2007
    Same author

    [Trends in the incidence of salmonellosis and campylobacteriosis in the Czech Republic].

    Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne·2004
    Same author

    [Can serologic markers be indicators of dietary errors in patients with celiac disease?].

    Vnitrni lekarstvi·2004
    Same author

    Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease.

    Physiological research·2003
    Same author

    Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor alpha antibody (infliximab) in Crohn's disease.

    Physiological research·2003